By a News Reporter-Staff News Editor at Pharma Business Week — According to news reporting originating from Washington, D.C., by NewsRx journalists, a U.S. Securities and Exchange Commission (SEC) filing by Minerva Neurosciences, Inc. (Form 424B4) was posted on July 1, 2014.
The SIC code for this company is 2834, Pharmaceutical Preparations.
There were 14 documents filed with this form. The SEC file number is 0001047469-14-005978.
The contact information for this company is 245 FIRST STREET, SUITE 1800, CAMBRIDGE MA 02142, 617-444-8444.
Our editors provided additional information about Form 424B4: Prospectus filed pursuant to Rule 424(b)(4).
A U.S. Securities and Exchange Commission filing is a formal document or financial statement submitted to the SEC by publicly-traded companies.
For additional information on this SEC filing see: http://www.sec.gov/Archives/edgar/data/1598646/0001047469-14-005978-index.html.
Keywords for this news article include: Pharmaceutical Preparations, SEC Filing, Minerva Neurosciences Inc..
Our reports deliver fact-based news of research and discoveries from around the world. Copyright 2014, NewsRx LLC
Read Next
